Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 1
1994 3
1995 1
1997 2
1999 1
2001 2
2003 1
2004 1
2005 9
2006 5
2007 4
2008 5
2009 7
2010 11
2011 10
2012 6
2013 20
2014 12
2015 16
2016 24
2017 26
2018 35
2019 35
2020 42
2021 40
2022 43
2023 36
2024 32

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

386 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Sands BE, Irving PM, Hoops T, Izanec JL, Gao LL, Gasink C, Greenspan A, Allez M, Danese S, Hanauer SB, Jairath V, Kuehbacher T, Lewis JD, Loftus EV Jr, Mihaly E, Panaccione R, Scherl E, Shchukina OB, Sandborn WJ; SEAVUE Study Group. Sands BE, et al. Lancet. 2022 Jun 11;399(10342):2200-2211. doi: 10.1016/S0140-6736(22)00688-2. Lancet. 2022. PMID: 35691323 Clinical Trial.
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.
Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A, Warusavitarne J, Buskens CJ, van Bodegraven AA, Brink MA, Consten ECJ, van Wagensveld BA, Rijk MCM, Crolla RMPH, Noomen CG, Houdijk APJ, Mallant RC, Boom M, Marsman WA, Stockmann HB, Mol B, de Groof AJ, Stokkers PC, D'Haens GR, Bemelman WA; LIR!C study group. Ponsioen CY, et al. Lancet Gastroenterol Hepatol. 2017 Nov;2(11):785-792. doi: 10.1016/S2468-1253(17)30248-0. Epub 2017 Aug 31. Lancet Gastroenterol Hepatol. 2017. PMID: 28838644 Clinical Trial.
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial.
Stevens TW, Haasnoot ML, D'Haens GR, Buskens CJ, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Mol B, Stokkers PCF, Bemelman WA, Ponsioen CY; LIR!C study group. Stevens TW, et al. Lancet Gastroenterol Hepatol. 2020 Oct;5(10):900-907. doi: 10.1016/S2468-1253(20)30117-5. Epub 2020 Jun 30. Lancet Gastroenterol Hepatol. 2020. PMID: 32619413 Clinical Trial.
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study.
Straatmijer T, Biemans VBC, Visschedijk M, Hoentjen F, de Vries A, van Bodegraven AA, Bodelier A, de Boer NKH, Dijkstra G, Festen N, Horjus C, Jansen JM, Jharap B, Mares W, van Schaik FDM, Ponsioen C, Romkens T, Srivastava N, van der Voorn MMPJA, West R, van der Woude J, Wolvers MDJ, Pierik M, van der Meulen-de Jong AE, Duijvestein M; Initiative on Crohn and Colitis. Straatmijer T, et al. Among authors: de boer nkh. Clin Gastroenterol Hepatol. 2023 Jan;21(1):182-191.e2. doi: 10.1016/j.cgh.2022.04.038. Epub 2022 May 26. Clin Gastroenterol Hepatol. 2023. PMID: 35644343 Free article.
Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions.
van der Horst MZ, Meijer Y, de Boer N, Guloksuz S, Hasan A, Siskind D, Wagner E; CLOZIN consortium; Okhuijsen-Pfeifer C, Luykx JJ. van der Horst MZ, et al. Among authors: de boer n. Psychiatry Res. 2023 Dec;330:115539. doi: 10.1016/j.psychres.2023.115539. Epub 2023 Oct 11. Psychiatry Res. 2023. PMID: 37988817 Free article.
[Oral manifestations of ulcerative colitis].
Tan CXW, Brand HS, de Boer NKH, Forouzanfar T. Tan CXW, et al. Among authors: de boer nkh. Ned Tijdschr Tandheelkd. 2017 May;124(5):243-247. doi: 10.5177/ntvt.2017.05.16217. Ned Tijdschr Tandheelkd. 2017. PMID: 28501878 Review. Dutch.
[Oral manifestations of Crohn's disease].
Tan CXW, de Boer NKH, Brand HS. Tan CXW, et al. Among authors: de boer nkh. Ned Tijdschr Tandheelkd. 2018 Jan;125(1):15-20. doi: 10.5177/ntvt.2018.01.17174. Ned Tijdschr Tandheelkd. 2018. PMID: 29377966 Review. Dutch.
[Coeliac disease and dentistry].
van Gils T, de Boer NK, Bouma G. van Gils T, et al. Among authors: de boer nk. Ned Tijdschr Tandheelkd. 2015 Sep;122(9):443-8. doi: 10.5177/ntvt.2015.09.15145. Ned Tijdschr Tandheelkd. 2015. PMID: 26397103 Review. Dutch.
Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.
van de Meeberg MM, Fidder HH, Oldenburg B, Sundaresan J, Struys EA, Montazeri NSM, Mares WGN, Mahmmod N, van Asseldonk DP, Lutgens MWMD, Kuyvenhoven JP, Rietdijk ST, Nissen LHC, Koehestanie P, de Boer NKH, de Jonge R, Bouma G, Bulatović Ćalasan M; Dutch Initiative on Crohn and Colitis (ICC). van de Meeberg MM, et al. Among authors: de boer nkh. Aliment Pharmacol Ther. 2023 Dec;58(11-12):1151-1162. doi: 10.1111/apt.17719. Epub 2023 Sep 28. Aliment Pharmacol Ther. 2023. PMID: 37767910
386 results